1 | DUPILUMAB (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 5件: 51 51, 97, 98, 160, 162 💬 |
2 | Dupilumab (blinded) (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 💬 |
3 | Dupilumab (open-label) (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 💬 |
4 | Dupilumab 300Mg Solution for Injection (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 51 51 💬 |
5 | Dupilumab Injection (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬 |
6 | Dupilumab Prefilled Syringe (Dupixent (TN)) | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 💬 |
7 | Dupixent | 1件: Dupilumab Dupilumab (Dupixent) | 1件: Dupilumab
Dupilumab
(Dupixent (TN)) 💬 | 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 3件: 98 98, 160, 162 💬 |